Description

CALCIQUICK D3 60K CAPS (1X4)

Indications

CALCIQUICK D3 60K CAPS is primarily indicated for the prevention and treatment of vitamin D deficiency and insufficiency in adults. It is particularly beneficial for individuals at risk of low vitamin D levels, including those with limited sun exposure, older adults, individuals with malabsorption syndromes, and patients with osteoporosis. The formulation is designed to support bone health and calcium metabolism, thereby reducing the risk of fractures and promoting overall skeletal strength.

Mechanism of Action

CALCIQUICK D3 contains cholecalciferol (vitamin D3), which plays a crucial role in calcium and phosphate homeostasis. Upon ingestion, vitamin D3 is converted in the liver to 25-hydroxyvitamin D and subsequently in the kidneys to its active form, 1,25-dihydroxyvitamin D. This active form enhances intestinal absorption of calcium and phosphate, promotes bone mineralization, and regulates parathyroid hormone secretion. By increasing the availability of calcium in the bloodstream, CALCIQUICK D3 supports various physiological functions, including muscle function and immune response.

Pharmacological Properties

CALCIQUICK D3 is characterized by its high bioavailability, allowing for effective absorption and utilization in the body. The formulation provides a substantial dose of vitamin D3, with each capsule containing 60,000 IU. This high-dose regimen is particularly useful for individuals with significant deficiencies or those requiring rapid correction of their vitamin D levels. Pharmacokinetic studies indicate that vitamin D3 is stored in adipose tissue and released slowly into circulation, providing a sustained effect over time. Furthermore, CALCIQUICK D3 is well-tolerated, with minimal gastrointestinal side effects reported in clinical usage.

Contraindications

CALCIQUICK D3 is contraindicated in individuals with a known hypersensitivity to vitamin D or any of the excipients in the formulation. It should also be avoided in patients with hypercalcemia, hyperphosphatemia, or conditions that predispose them to elevated calcium levels, such as primary hyperparathyroidism. Additionally, caution is advised in individuals with kidney disease, as impaired renal function can affect vitamin D metabolism and calcium balance.

Side Effects

While CALCIQUICK D3 is generally well tolerated, some individuals may experience side effects. Commonly reported adverse effects include gastrointestinal disturbances such as nausea, vomiting, constipation, and diarrhea. In rare cases, excessive intake of vitamin D can lead to hypercalcemia, which may manifest as weakness, fatigue, headache, dry mouth, or confusion. Patients are advised to monitor for these symptoms and consult a healthcare professional if they occur.

Dosage and Administration

The recommended dosage of CALCIQUICK D3 is typically one capsule (60,000 IU) taken once a week or as directed by a healthcare provider. This regimen is designed to achieve optimal serum levels of vitamin D while minimizing the risk of toxicity. It is important to take the capsule with food to enhance absorption. Patients should follow their healthcare provider’s instructions regarding duration of therapy, as individual needs may vary based on baseline vitamin D levels and specific health conditions.

Interactions

CALCIQUICK D3 may interact with certain medications and supplements. For instance, corticosteroids can reduce the absorption of calcium and impair the metabolism of vitamin D, potentially necessitating dosage adjustments. Additionally, medications that affect calcium levels, such as thiazide diuretics, may increase the risk of hypercalcemia when taken concurrently with vitamin D supplements. Patients should inform their healthcare provider of all medications and supplements they are taking to avoid potential interactions.

Precautions

Before starting CALCIQUICK D3, patients should undergo a thorough assessment of their vitamin D status, particularly if they have risk factors for deficiency. Regular monitoring of serum calcium and vitamin D levels is recommended during treatment, especially in individuals with a history of hypercalcemia or renal impairment. Pregnant and breastfeeding women should also consult their healthcare provider before use, as vitamin D requirements may differ during these periods. It is essential to adhere to the recommended dosage to prevent the risk of vitamin D toxicity.

Clinical Studies

Several clinical studies have demonstrated the efficacy of vitamin D supplementation in improving bone health and preventing fractures. A randomized controlled trial published in the Journal of Clinical Endocrinology and Metabolism showed that high-dose vitamin D supplementation significantly increased serum 25-hydroxyvitamin D levels and improved bone mineral density in older adults. Another study in the American Journal of Clinical Nutrition reported that adequate vitamin D levels are associated with a reduced risk of falls in the elderly population. These findings support the use of CALCIQUICK D3 as an effective intervention for managing vitamin D deficiency and promoting skeletal health.

Conclusion

CALCIQUICK D3 60K CAPS is a potent formulation designed to address vitamin D deficiency and support overall bone health. With its high bioavailability and effective dosing regimen, it serves as a valuable supplement for individuals at risk of low vitamin D levels. As with any supplement, it is crucial for patients to consult with healthcare professionals to determine their specific needs and to monitor for any potential side effects or interactions. By ensuring adequate vitamin D intake, individuals can enhance their bone health and overall well-being.